KRISTY DOOLEY-REINHEIMER: Open Payments
NPI 1295458438 · TOWANDA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 37 payments from 17 companies in 2025. Trend: 2023 $254 · 2024 $504 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $118 |
| Novo Nordisk Inc | 5 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $78 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| ABBVIE INC. | 2 | $37 |
| Dexcom, Inc. | 2 | $37 |
| Radius Health, Inc. | 1 | $32 |
| Astellas Pharma US Inc | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Ardelyx, Inc. | 1 | $28 |
Products named: MOUNJARO, Kerendia, VERQUVO, VRAYLAR, Dexcom G6 Transmitter, Ozempic, Wegovy, Binosto.
Industry payments across PA — which companies pay providers there.
